08:32 AM EDT, 05/13/2025 (MT Newswires) -- CG Oncology ( CGON ) reported a Q1 net loss Tuesday of $0.45 per share, widening from a loss of $0.36 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.40 per share.
License and collaboration revenue for the quarter ended March 31 was $52,000, down from $529,000 a year earlier.
Analysts surveyed by FactSet expected $200,000.